Related Experiment Videos
Resection and local therapy for liver metastases
P M Schlag1, T Benhidjeb, C Stroszczynski
1Klinik für Chirurgie und Chirurgische Onkologie, Lindenberger Weg 80, Berlin D-13122, Germany.
Best Practice & Research. Clinical Gastroenterology
|April 24, 2002
Summary
Surgical resection offers potential cure for liver metastases, but only a small percentage of patients are eligible. Re-resection can improve survival in selected cases, and new chemotherapy and interventional strategies are emerging.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Medical Oncology
Background:
- Liver metastases are common in malignant tumors, particularly from colorectal primaries.
- Surgical resection is the only potentially curative treatment for liver metastases, with a 30% 5-year survival rate.
- Only 10-15% of patients with colorectal liver metastases are candidates for curative resection, highlighting the need for accurate staging.
Purpose of the Study:
- To review current treatment strategies for liver metastases.
- To evaluate the role of surgical resection, re-resection, and adjuvant therapies.
- To explore emerging interventional and combined treatment modalities.
Main Methods:
- Review of existing data on liver metastases treatment.
- Analysis of outcomes for surgical resection and re-resection.
- Evaluation of adjuvant chemotherapy, pre-operative chemotherapy, and neoadjuvant chemotherapy.
- Consideration of interventional strategies like ablation and combined modalities.
Main Results:
- Re-resection of liver metastases can yield long-term survival in carefully selected patients.
- Adjuvant chemotherapy has historically shown limited effectiveness, but pre-operative and neoadjuvant chemotherapy show promise.
- Interventional strategies and combined modalities are being investigated to improve treatment outcomes.
Conclusions:
- Accurate patient selection is crucial for successful surgical resection of liver metastases.
- Neoadjuvant chemotherapy and interventional techniques represent promising future directions for managing liver metastases.
- Multimodal approaches may enhance treatment efficacy for liver metastases.